Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Rung Mo

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivoShu-Ching Shih, Meihua Ju, Nan Liu, et al.
Plos One|October 1, 2009
Splenectomy normalizes hematocrit in murine polycythemia veraJan-Rung Mo, Anjili Mathur, Minilik Angagaw, et al.
Biochemical Pharmacology|May 11, 2019
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylationAlvin Z Lu, Ryan Abo, Yue Ren, et al.
The American Journal of Pathology|January 13, 2011
Progranulin is a chemoattractant for microglia and stimulates their endocytic activityFiona Pickford, Jacob Marcus, Luiz Miguel Camargo, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2010
The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to leadTony Siu, Ekaterina S Kozina, Joon Jung, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasmsAndrew M Haidle, Anna A Zabierek, Kaleen K Childers, et al.
Biochemical Pharmacology|May 6, 2009
An inhibitor of Janus kinase 2 prevents polycythemia in miceAnjili Mathur, Jan-Rung Mo, Manfred Kraus, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Plos One|May 25, 2012
Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia veraManfred Kraus, Yuxun Wang, Dan Aleksandrowicz, et al.
Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2003
Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivoShu-Ching Shih, Meihua Ju, Nan Liu, et al.
Plos One|October 1, 2009
Splenectomy normalizes hematocrit in murine polycythemia veraJan-Rung Mo, Anjili Mathur, Minilik Angagaw, et al.
Biochemical Pharmacology|May 11, 2019
Enabling drug discovery for the PARP protein family through the detection of mono-ADP-ribosylationAlvin Z Lu, Ryan Abo, Yue Ren, et al.
The American Journal of Pathology|January 13, 2011
Progranulin is a chemoattractant for microglia and stimulates their endocytic activityFiona Pickford, Jacob Marcus, Luiz Miguel Camargo, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2010
The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to leadTony Siu, Ekaterina S Kozina, Joon Jung, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2014
Thiophene carboxamide inhibitors of JAK2 as potential treatments for myleoproliferative neoplasmsAndrew M Haidle, Anna A Zabierek, Kaleen K Childers, et al.
Biochemical Pharmacology|May 6, 2009
An inhibitor of Janus kinase 2 prevents polycythemia in miceAnjili Mathur, Jan-Rung Mo, Manfred Kraus, et al.
Cell Chemical Biology|March 11, 2021
A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explantsLaurie B Schenkel, Jennifer R Molina, Kerren K Swinger, et al.
Plos One|May 25, 2012
Efficacious intermittent dosing of a novel JAK2 inhibitor in mouse models of polycythemia veraManfred Kraus, Yuxun Wang, Dan Aleksandrowicz, et al.
Cancer Cell|August 10, 2021
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunityJoseph M Gozgit, Melissa M Vasbinder, Ryan P Abo, et al.
Pageof 1